Stay updated on Filgotinib and Lanraplenib in Female CLE Clinical Trial

Sign up to get notified when there's something new on the Filgotinib and Lanraplenib in Female CLE Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Filgotinib and Lanraplenib in Female CLE Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of study content, signaling restricted access. A simple header and a Home link are shown.
    Difference
    18%
    Check dated 2026-09-23T21:39:36.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision updated from v3.6.6 to v3.7.0 on the page, indicating an internal platform update. No study content or surrounding page information was modified.
    Difference
    0.0%
    Check dated 2026-09-16T22:26:23.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page revision label changed from v3.6.5 to v3.6.6, indicating a new version of the page. It does not modify the study details, eligibility criteria, or results.
    Difference
    0.0%
    Check dated 2026-09-02T19:53:26.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page revision updated from v3.6.4 to v3.6.5, indicating a small backend/template update rather than substantive changes to visible content.
    Difference
    0.0%
    Check dated 2026-08-12T20:37:14.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.3 to v3.6.4, reflecting a minor version update to the page metadata rather than substantive changes to the study details.
    Difference
    0.0%
    Check dated 2026-07-28T13:42:37.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    The page shows a new revision label, updating from Revision: v3.6.0 to Revision: v3.6.3, reflecting a newer site release. This update appears to be a software revision rather than a change to the study data or page content.
    Difference
    0.0%
    Check dated 2026-06-30T02:30:44.000Z thumbnail image

Stay in the know with updates to Filgotinib and Lanraplenib in Female CLE Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Filgotinib and Lanraplenib in Female CLE Clinical Trial page.